These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

400 related items for PubMed ID: 11481866

  • 1. [A behavioral and neurochemical study on the mechanism of the anxiolytic effect of monoamine oxidase inhibitors].
    Maki Y.
    Hokkaido Igaku Zasshi; 2001 May; 76(3):133-42. PubMed ID: 11481866
    [Abstract] [Full Text] [Related]

  • 2. Effect of co-administration of subchronic lithium pretreatment and acute MAO inhibitors on extracellular monoamine levels and the expression of contextual conditioned fear in rats.
    Kitaichi Y, Inoue T, Nakagawa S, Izumi T, Koyama T.
    Eur J Pharmacol; 2006 Feb 27; 532(3):236-45. PubMed ID: 16487506
    [Abstract] [Full Text] [Related]

  • 3. Monoamine oxidase inhibitors reduce conditioned fear stress-induced freezing behavior in rats.
    Maki Y, Inoue T, Izumi T, Muraki I, Ito K, Kitaichi Y, Li X, Koyama T.
    Eur J Pharmacol; 2000 Oct 20; 406(3):411-8. PubMed ID: 11040348
    [Abstract] [Full Text] [Related]

  • 4. Combined treatment with MAO-A inhibitor and MAO-B inhibitor increases extracellular noradrenaline levels more than MAO-A inhibitor alone through increases in beta-phenylethylamine.
    Kitaichi Y, Inoue T, Nakagawa S, Boku S, Izumi T, Koyama T.
    Eur J Pharmacol; 2010 Jul 10; 637(1-3):77-82. PubMed ID: 20406628
    [Abstract] [Full Text] [Related]

  • 5. [Neurochemical and behavioral study on the mechanism of the antidepressant and anxiolytic effect of co-administration of lithium and monoamine oxidase inhibitors].
    Kitaichi Y.
    Hokkaido Igaku Zasshi; 2004 Jan 10; 79(1):93-101. PubMed ID: 14978979
    [No Abstract] [Full Text] [Related]

  • 6. Effects of co-administration of antidepressants and monoamine oxidase inhibitors on 5-HT-related behavior in rats.
    Izumi T, Iwamoto N, Kitaichi Y, Kato A, Inoue T, Koyama T.
    Eur J Pharmacol; 2007 Jun 22; 565(1-3):105-12. PubMed ID: 17400208
    [Abstract] [Full Text] [Related]

  • 7. [Effects of conditioned fear stress on monoaminergic systems in the rat brain].
    Inoue T.
    Hokkaido Igaku Zasshi; 1993 May 22; 68(3):377-90. PubMed ID: 7686527
    [Abstract] [Full Text] [Related]

  • 8. Effect of co-administration of varenicline and antidepressants on extracellular monoamine concentrations in rat prefrontal cortex.
    Rollema H, Wilson GG, Lee TC, Folgering JH, Flik G.
    Neurochem Int; 2011 Jan 22; 58(1):78-84. PubMed ID: 21056607
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Potentiation of 3,4-methylenedioxymethamphetamine-induced 5-HT release in the rat substantia nigra by clorgyline, a monoamine oxidase A inhibitor.
    Hewton R, Salem A, Irvine RJ.
    Clin Exp Pharmacol Physiol; 2007 Oct 22; 34(10):1051-7. PubMed ID: 17714093
    [Abstract] [Full Text] [Related]

  • 11. L-methamphetamine and selective MAO inhibitors decrease morphine-reinforced and non-reinforced behavior in rats; Insights towards selegiline's mechanism of action.
    He S, Grasing K.
    Pharmacol Biochem Behav; 2006 Dec 22; 85(4):675-88. PubMed ID: 17157368
    [Abstract] [Full Text] [Related]

  • 12. Monoamine oxidase A rather than monoamine oxidase B inhibition increases nicotine reinforcement in rats.
    Guillem K, Vouillac C, Azar MR, Parsons LH, Koob GF, Cador M, Stinus L.
    Eur J Neurosci; 2006 Dec 22; 24(12):3532-40. PubMed ID: 17229101
    [Abstract] [Full Text] [Related]

  • 13. 2'-NH2-MPTP in Swiss Webster mice: evidence for long-term (6-month) depletions in cortical and hippocampal serotonin and norepinephrine, differential protection by selective uptake inhibitors or clorgyline and functional changes in central serotonin neurotransmission.
    Andrews AM, Murphy DL.
    J Pharmacol Exp Ther; 1993 Dec 22; 267(3):1432-9. PubMed ID: 8263805
    [Abstract] [Full Text] [Related]

  • 14. Monoamine oxidase-A inhibitors and dopamine metabolism in rat caudatus: evidence that an increased cytosolic level of dopamine displaces reversible monoamine oxidase-A inhibitors in vivo.
    Colzi A, D'Agostini F, Cesura AM, Borroni E, Da Prada M.
    J Pharmacol Exp Ther; 1993 Apr 22; 265(1):103-11. PubMed ID: 8473998
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of monoamine oxidase type A, but not type B, is an effective means of inducing anticonvulsant activity in the kindling model of epilepsy.
    Löscher W, Lehmann H, Teschendorf HJ, Traut M, Gross G.
    J Pharmacol Exp Ther; 1999 Mar 22; 288(3):984-92. PubMed ID: 10027835
    [Abstract] [Full Text] [Related]

  • 16. Therapeutic applications of selective and non-selective inhibitors of monoamine oxidase A and B that do not cause significant tyramine potentiation.
    Youdim MB, Weinstock M.
    Neurotoxicology; 2004 Jan 22; 25(1-2):243-50. PubMed ID: 14697899
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of methamphetamine-induced hyperlocomotion in mice by clorgyline, a monoamine oxidase-a inhibitor, through alteration of the 5-hydroxytriptamine turnover in the striatum.
    Kitanaka N, Kitanaka J, Takemura M.
    Neuroscience; 2005 Jan 22; 130(2):295-308. PubMed ID: 15664686
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. 5-HT1A receptor agonist affects fear conditioning through stimulations of the postsynaptic 5-HT1A receptors in the hippocampus and amygdala.
    Li X, Inoue T, Abekawa T, Weng S, Nakagawa S, Izumi T, Koyama T.
    Eur J Pharmacol; 2006 Feb 17; 532(1-2):74-80. PubMed ID: 16460727
    [Abstract] [Full Text] [Related]

  • 20. In vitro effects on monoamine uptake and release by the reversible monoamine oxidase-B inhibitors lazabemide and N-(2-aminoethyl)-p-chlorobenzamide: a comparison with L-deprenyl.
    Bondiolotti GP, Galva MD, Villa F, Sciaba L, Picotti GB.
    Biochem Pharmacol; 1995 Jun 29; 50(1):97-102. PubMed ID: 7605351
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.